Ben Taylor
Vermögen: 4 Mio $ am 31.05.2026
Vermögen: 4 Mio $ am 31.05.2026
Ben R.
Taylor is Chief Financial Officer & President-UK Region at Recursion Pharmaceuticals, Inc. since 2024.
Formerly, Chief Financial Officer & Executive Director at Exscientia AI Ltd. from 2020 to 2024.
Chief Financial & Strategy Officer, Director at Exscientia Ltd. Head-Emerging Pharm at Goldman Sachs & Co. LLC from 2012 to 2016.
Head-Commercial Pharm at Barclays Capital, Inc. from 2016 to 2017.
President & Chief Financial Officer at Tyme Technologies, Inc. from 2017 to 2020.
Chief Financial Officer at Aetion, Inc. in 2020.
Education includes undergraduate degree from Brown University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.06.2026 | 1’101’876 ( 0.21% ) | 4 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 20.11.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Provides AI and machine learning techniques based drug discovery services | Finanzdirektor/CFO | 01.11.2024 |
Aetion, Inc.
Aetion, Inc. Packaged SoftwareTechnology Services Develops real-world evidence platform that helps in decision-making activities related to healthcare sector | Finanzdirektor/CFO | 01.11.2020 |
| TYME TECHNOLOGIES, INC. | Finanzdirektor/CFO | 01.08.2020 |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01.01.2017 |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01.02.2016 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 8 |
|---|---|
Tyme Technologies, Inc.
Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops cancer metabolism-based therapeutics | Health Technology |
Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that combines biology, chemistry, automation, data science and engineering to industrialize drug discovery | Health Technology |
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Aetion, Inc.
Aetion, Inc. Packaged SoftwareTechnology Services Develops real-world evidence platform that helps in decision-making activities related to healthcare sector | Technology Services |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Provides AI and machine learning techniques based drug discovery services | Health Technology |
Exscientia Plc
Exscientia Plc Packaged SoftwareTechnology Services Function as an investment holding company whose subsidiaries provides artificial intelligence and machine learning services | Technology Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen